| NCT06774131 | A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer | RECRUITING | PHASE3 | 2025-05-02 | 2027-03-31 | 2026-03-31 |
| NCT06331299 | A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer | RECRUITING | PHASE3 | 2024-08-29 | 2026-08 | 2025-08 |
| NCT05375903 | A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) | ACTIVE_NOT_RECRUITING | PHASE1 | 2022-06-01 | 2025-12 | 2025-12 |
| NCT05243550 | A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-03-01 | 2028-02 | 2023-04-26 |
| NCT05136898 | Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC) | COMPLETED | PHASE3 | 2021-11-30 | 2023-02-02 | 2023-02-02 |
| NCT04688931 | A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer | TERMINATED | PHASE3 | 2021-02-19 | 2023-03-17 | 2023-03-17 |
| NCT04006691 | Efficacy and Safety of UGN-101 in Recurrent Patients | WITHDRAWN | PHASE3 | 2019-10-01 | 2020-03-31 | 2020-03-31 |
| NCT03558503 | A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer | COMPLETED | PHASE2 | 2018-10-15 | 2020-10-21 | 2020-01-03 |
| NCT02793128 | The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study | COMPLETED | PHASE3 | 2017-04-04 | 2020-03-05 | 2019-04-05 |
| NCT02674269 | Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2") | WITHDRAWN | PHASE1, PHASE2 | 2016-10 | 2016-10 | 2016-10 |
| NCT02307487 | Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients | COMPLETED | PHASE2 | 2014-12 | 2017-06 | 2016-04 |
| NCT02179099 | Safety and Efficacy of Intravesical Botulinum Toxin in TC-3 Gel in OAB Patients | TERMINATED | PHASE1, PHASE2 | 2014-07 | 2016-02 | 2015-11 |
| NCT01997983 | Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients | COMPLETED | PHASE1, PHASE2 | 2013-11 | 2015-08 | 2014-04 |
| NCT01803295 | Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC | COMPLETED | NA | 2013-06 | 2017-06 | 2016-07 |
| NCT01799499 | A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC) | WITHDRAWN | NA | 2013-03 | 2013-03 | 2013-03 |
| NCT02891460 | Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients | COMPLETED | NA | 2013-01 | 2015-03 | 2014-02 |
| NCT01648010 | Safety and Tolerability Study Which Evaluate Intravesical Instillation With Mitomycin C Mixed With TC-3 Drug Retaining Hydrogel Device In Patients With Muscle Invasive Bladder Cancer | COMPLETED | NA | 2011-11 | 2013-05 | 2013-05 |